Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →

BISMUTH SUBSALICYLA

Active
SPE2DP-26-T-4940Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

This contract is for the procurement of Bismuth Subsalicylate tablets, specifically 262 mg chewable tablets provided in individually sealed packages of 30. The requirement specifies a total quantity of 2 packages under NSN 6505-01-443-7607, with a delivery timeline of 20 days after order. The product must adhere to FDA regulations and strict shelf-life requirements, maintaining a total shelf life of 34 months, with at least 21 months remaining upon delivery to the government. Packaging must follow commercial standards and be secured in sealed unit containers to prevent damage, with all marking adhering to Medical Marking Standard No. 1. The contract prohibits the intentional addition of mercury or mercury-containing compounds. Delivery is set as FOB Destination, and the procurement is managed by the Department of Defense Medical Supply Chain Pharmacy FSA.

General Info

Procurement of two 30-count Bismuth Subsalicylate packages delivered within 20 days.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSAView Agency

NAICS

325412 - Pharmaceutical Preparation ManufacturingView NAICS

Place of Performance

800 SEAL BEACH BLVD BLDG 14 NSW, SEAL BEACH, CA, 90740-5607, USA

Set-Aside

NONE

Documents

(1)

SPE2DP-26-T-4940 Request for Quotations

PDF19 pagesrfq

AI Contract Breakdown

Uniform Contract Format

What is UCF?

Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseSolicitation
Posted

Solicitation

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Contacts1 person available
OfficeUSA
Organization / Agency
Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
View Agency Profile
Office AddressUSA
Contacts

Full Description

Show more
BISMUTH SUBSALICYLA
BISMUTH SUBSALICYLATE TABLETS
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS
SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED
IN A SUITABLE SEALED UNIT CONTAINER CAPABLE
OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR
BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL
EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN
NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND
SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT
THE LOWEST RATE, TO POINT OF DELIVERY CALLED
FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING
STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES
TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1
(MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA
TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
262 MG, CHEWABLE, INDIVIDUALLY SEALED, 30'S
U/I "PG" 30'S
SHALL HAVE A SHELF LIFE OF 34 MONTHS.
NOT LESS THAN 21 MONTHS SHALL HAVE ELAPSED FROM DATE
OF MANUFACTURE TO DATE OF DELIVERY TO THE GOVERNMENT.
1 PG = 30 TT
SPE2DP-26-T-4940
SECTION B
MERCURY OR MERCURY CONTAINING COMPOUNDS SHALL
NOT BE INTENTIONALLY ADDED TO<(>,<)> OR COME IN DIRECT
CONTACT WITH<(>,<)> ANY HARDWARE OR SUPPLIES FURNISHED
UNDER THIS CONTRACT. EXCEPTION: FUNCTIONAL MERCURY
USED IN BATTERIES, FLUORESCENT LIGHTS, REQUIRED
INSTRUMENTS; SENSORS OR CONTROLS; WEAPON SYSTEMS;
AND CHEMICAL ANALYSIS REAGENTS SPECIFIED BY NAVSEA.
PORTABLE FLUORESCENT LAMPS AND PORTABLE INSTRUMENTS
CONTAINING MERCURY SHALL BE SHOCK PROOF AND CONTAIN
A SECOND BOUNDARY OF CONTAINMENT OF THE MERCURY OR
MERCURY COMPOUND. (IAW NAVSEA 5100-003D).
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description. RS016: Shelf-life requirement RS001 for a TYPE I (CODE M) item with a shelf life of 24 months (non-extendable) applies to this item.
THE HARVARD DRUG GROUP, L.L.C. 1LEZ0 P/N NDC00904-7205-46 THE PROCTER & GAMBLE DISTRIBUTING LLC 74188 P/N NDC37000-0477-09
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7018204303 0001 PG 2.000
NSN/MATERIAL:6505014437607
DELIVERY (IN DAYS):0020
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
SPECIAL NSN/Part Number: 6505-01-443-7607 Quantity: 2 PG Purchase Request: 7018204303QTY: 2 Delivery: 20 days ADO

Similar Contracts

Same NAICS industry code

NAICS: 325412
New
Federal
6505--2027-2028 Influenza Virus Vaccine
Solicitation # 36E79726R0035
Solicitation 36E79726R0035 is an unrestricted FAR Part 12 commercial-item procurement issued by the Department of Veterans Affairs National Acquisition Center for the supply of Influenza Virus Vaccines for the 2027-2028 season. The contract requires the delivery of trivalent or quadrivalent vaccines in pre-filled single-dose syringes with plunger and Luer lock needle attachments, provided in boxes of 10. The vaccines must be latex and preservative free, with specific FDA approval and labeling required for pediatric populations (6 to 35 months) and seniors (65 years and older). Final vaccine presentation is based on World Health Organization recommendations, with a preference for Trivalent presentations if both Trivalent and Quadrivalent options are commercially available. The award will be made on a per solicitation line item basis for the VA, Bureau of Prisons, Indian Health Service, and the Captain James A. Lovell Federal Health Care Center. Deliveries are Free On Board Destination to government facilities across the United States, Puerto Rico, and the Philippines. Most facilities require a two-part delivery schedule, with at least 50 percent of the order delivered between August 15 and September 15, 2027, and the remainder by October 15, 2027; however, the FHCC must receive 100 percent of its awarded quantity by September 15, 2027. Offerors must provide the full quantity for any line item bid, and final pricing must include the Cost Recovery Fee and Federal Excise Tax.
Nac Pharmaceuticals (36E797)

POSTED

about 9 hours ago

DEADLINE

in 15 days
View Details
NAICS: 325412
New
Federal
6505--FDG Radiopharmaceutical
Solicitation # 36C24426Q0900
Solicitation 36C24426Q0900 is a request for quotation issued by the Department of Veterans Affairs Network Contracting Office 4 to secure a Nuclear Regulatory Commission licensed vendor for the supply of Fluorodeoxyglucose (FDG) radiopharmaceuticals. These products serve as tracers for PET/CT scans to detect cancer, evaluate inflammation, and assess organ function at the Philadelphia VA Medical Center. The estimated period of performance runs from October 14, 2026, to October 13, 2031. This is a non-set-aside acquisition for commercial items, with quotes due by September 17, 2026, at 6:00 AM ET. The contractor must adhere to strict packaging and labeling standards, ensuring all shipping containers are marked as radioactive with proper exposure levels and that unit doses include precise preparation and expiration data. Additionally, the vendor must provide bar-labeled inserts compatible with the nuclear medicine information management system, assuming all costs for data migration and training if their system differs from the current Pinestar NMIS. Award will be based on a pairwise comparison of the best overall response, evaluating price, technical capability, socioeconomic considerations, and past performance from the last three years. Payments will be processed via Electronic Funds Transfer through the System for Award Management, with electronic invoicing required via the Tungsten Network.
244-NETWORK Contract Office 4 (36C244)

POSTED

about 9 hours ago

DEADLINE

in 9 days
View Details

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 650+ contractors already using CLEATUS